The $100 million PROTECT-Cog study is a global prevention trial for older adults at higher risk of cognitive decline. It does not enroll people already diagnosed with dementia for treatment, which matters for spouses deciding who might join. PROTECT-Cog means Prevention of Risk fOr cogniTive dEcline through Combined Therapy. The Alzheimer's Association announced the trial on July 13, 2026 at AAIC 2026 in London as a prevention study combining lifestyle change with a metabolism drug such as a GLP-1 agonist, the Alzheimer's Association announcement.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- Who the trial is designed to study
- Who is not part of the study
- What participation asks of couples
- Why spouses and partners face higher stakes
Who the trial is designed to study
The trial will enroll older adults at increased risk for cognitive decline. The goal is to reduce decline, mild cognitive impairment and dementia before diagnosis, the Alzheimer's Association announcement. The design builds on U.S.
POINTER. That study randomized 2,111 cognitively unimpaired adults around age 68 with elevated risk from sedentary lifestyle, diet and cardiometabolic factors, according to NeurologyLive's trial summary. For spouses, the practical point is risk status. A partner with high blood pressure, diabetes, poor diet, low activity or early memory concerns fits the prevention focus better than a partner seeking treatment after diagnosis.
Who is not part of the study
People already diagnosed with dementia are not the treatment population. PROTECT-Cog tests prevention in at-risk adults, not a therapy to reverse diagnosed disease. Only a subset of participants will also receive the metabolism or immune drug.
The main comparison is intensive-coaching lifestyle against structured-lite lifestyle, according to NeurologyLive's trial summary. Medscape reported at launch that the specific drug and other trial details had yet to be finalized. Couples should therefore watch the trial sites for the final eligibility list before making plans.
What participation asks of couples
Participants are followed for three years. They receive comprehensive cognitive and health evaluations about every six months, according to TechTimes reporting on the AAIC launch.
That schedule affects both partners. Travel, time off, diet changes, exercise sessions and coaching calls become household work even when only one spouse enrolls.
- Check whether the at-risk partner meets age and risk-factor criteria at the local site
- Ask which lifestyle arm requires more visits, coaching and home practice
- Ask whether partners may attend coaching, testing or safety visits
- Plan for three years of visits, medications, side-effect checks and lifestyle tracking
Why spouses and partners face higher stakes
A separate Taiwan study of nearly one million married people found dementia risk 74 percent higher in wives and 69 percent higher in husbands with an affected spouse, according to StudyFinds reporting on the JAMA research. The finding points to shared habits and caregiving strain.
Diet, sleep, activity, blood pressure, hearing loss, depression and social isolation often affect both members of a household. Partners can act now without waiting for enrollment. Control blood pressure and blood sugar, walk daily together, protect sleep, treat hearing loss, stay socially active and ask a primary-care clinician about memory screening and prevention programs.
You Might Also Like
- The Third FDA-Cleared Alzheimer’s Blood Biomarker Test in 2026: A Source-Checked Briefing for Memory Clinic Patients
- Tauklarify Tau PET vs Alzheimer’s Blood Tests in 2026: A Source-Checked Briefing for Memory Clinic Patients
- The WHO 45% Modifiable Dementia Risk Estimate in 2026: How Adults Over 65 Can Build a Realistic Brain Health Plan
